Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 842 results for "hcv"

Team Tracks HepC Virus Mutations
HCPLive

Team Tracks HepC Virus Mutations

Researchers applied a new technique to investigate the hepatitis C virus (HCV) genome, and gained insights into the extreme mutability of the virus. The research was conducted by Ron Geller, PhD, of the Cavanilles Institute of Biodiversity and ... HCPLive, 14 hours ago
[x]  
Business Standard India

Passenger Vehicle segment to grow at 9.5 per cent, M&HCV at 15 per cent in 2017, says Icra

The Indian passenger vehicle (PV) industry's domestic volumes are expected to grow by 9.5% in 2017, while that of medium & heavy commercial vehicles (M&HCV) is expected to grow by 15%, said Icra in its study released on Thursday. Supported by the ...
 Financial Express6 days ago First time car buyers to fuel demand this year: ICRA  Smart Investor6 days ago Demand in most vehicle segments set to pick up  The Financial Chronicle1 month ago

Captain to steer Ashok Leyland's HCV segment fortunes

at 11:35 am | The Captain range from Ashok Leyland features an indigenously designed, factory-made cab based on the best principles of ergonomics and international styling to deliver superior comfort, a longer life and optimal performance. The ...
 MotorIndia1 week ago

Cipla partners with FIND to increase detection of Hepatitis C

NEW DELHI: In a move that could increase detection of Hepatitis C (HCV) cases—a majority of which are currently undiagnosed—Indian pharmaceutical giant Cipla has partnered with a global non-profit focussed on delivering affordable diagnostic tools. Only ...
 Economic Times2 weeks ago
Rush Lane

Tata Motors sales increase marginally in March; M&HCV grows 24%

...
 Myiris1 month ago Tata Motors sees growth of 24% in M&HCVs  Deccan Herald1 month ago Tata Motors strengthens passenger vehicle sales in April 2016  Biggaddi1 day ago Tata Motors jumps on reporting 10% growth in April sales  Finalaya.com2 days ago
[x]  

Achillion Reports First Quarter 2016 Financial Results and Provides Update on Clinical Programs

Tuesday, May 03, 2016 - Company provides update on HCV collaboration with Janssen; Phase 2b combination study evaluating doublet and triplet regimens for six and eight weeks anticipated to begin in Q3 2016 - Strong balance sheet to support ...
 Pharma Focus Asia1 day ago BRIEF-Achillion reports Q1 loss per share $0.13  Reuters UK1 day ago REGULUS THERAPEUTICS : Reports First Quarter 2016 Financial Results and Recent Highlights  4 Traders2 days ago Regulus Reports First Quarter 2016 Financial Results and Recent Highlights  Financial Buzz2 days ago
[x]  
Med India

HCV drugs may hasten liver cancer recurrence

Researchers have unexpectedly found early tumor recurrence in patients with hepatitis C virus (HCV)-related hepatocellular carcinoma in patients undergoing interferon-free therapy, according to a new study. The success of direct-acting antivirals ...
 Medical Economics2 days ago Inflammation, gut dysbiosis persist despite SVR after HCV therapy  Healio1 week ago Top HCV stories from International Liver Congress  Healio1 week ago HCV Drug Treatment - New Frontiers  Med India4 weeks ago

Cocrystal begins Phase I trial of CC-31244 in healthy and HCV-infected subjects

Cocrystal Pharma has begun a Phase Ia/Ib clinical trial of CC-31244, a pan-genotypic, potent NS5B non-nucleoside inhibitor (NNI), to treat chronic hepatitis C virus (HCV) infection. Hepatitis C is a viral infection of the liver and as per the ...
 Drug Development Technology1 week ago Cocrystal Pharma Receives Health Canada Approval to Conduct Phase I Clinical Study for CC-31244 in Healthy and HCV-Infected Subjects  PharmaVOICE1 week ago Cocrystal Pharma, Inc. (COCP: OTCQB) | Cocrystal Pharma Receives Health Canada Approval to Conduct Phase I Clinical Study for CC-31244 in Healthy and HCV-Infected Subjects  OTC Markets1 week ago OPKO HEALTH : Cocrystal Pharma Receives Health Canada Approval to Conduct Phase I Clinical Study for CC-31244 in Healthy and HCV-Infected Subjects  4 Traders1 week ago
[x]  
India Infoline

Auto buzz: Ashok Leyland emerges winner in M&HCV market, Tiago in demand, and many more

German luxury carmaker BMW has appointed Frank Schloeder as acting President of its Indian operations with effect from May 1. German luxury carmaker BMW has appointed Frank Schloeder as acting President of its Indian operations with effect from May 1.
 India Infoline2 weeks ago
India Infoline

Ashok Leyland tops industry sales growth in FY16

The Hinduja group company emerged as a clear winner in the Medium & Heavy Commercial Vehicles (M&HCV) market during FY16, capturing better market share than rivals, according to the paper. Ashok Leyland Ltd surpassed industry sales in goods and passenger ...
 India Infoline2 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - hcv
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less